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We present results on using cooperative interactions to shield liposomes by incorporating multiple hydrophobic anchoring sites on
polyethylene glycol (PEG) polymers. The hydrophobically-modified PEGs (HMPEGs) are comb-graft polymers with strictly alternating
monodisperse PEG blocks (Mw=6, 12, or 35 kDa) bonded to C18 stearylamide hydrophobes. Cooperativity is varied by changing the degree
of oligomerization at a constant ratio of PEG to stearylamide. Fusogenic liposomes prepared from N-C12-DOPE:DOPC 7:3 (mol:mol) were
equilibrated with HMPEGs. Affinity for polymer association to liposomes increases with the degree of oligomerization; equilibrium constants
(given as surface coverage per equilibrium concentration of free polymer) for 6 kDa PEG increased from 6.1F0.8 (mg/m2)/(mg/ml) for 2.5
loops to 78.1F12.2 (mg/m2)/(mg/ml) for 13 loops. In contrast, the equilibrium constant for distearoylphosphatidylethanolamine-
poly(ethylene glycol) (DSPE-PEG5k) was 0.4F0.1 (mg/m2)/(mg/ml).
The multi-loop HMPEGs demonstrate higher levels of protection from complement binding than DSPE-PEG5k. Greater protection does
not correlate with binding strength alone. The best shielding was by HMPEG6k-DP3 (with three 6 kDa PEG loops), suggesting that PEG
chains with adequate surface mobility provide optimal protection from complement opsonization. Complement binding at 30 min and 12 h
demonstrates that protection by multi-looped PEGs is constant whereas DSPE-PEG5k initially protects but presumably partitions off of the
surface at longer times.
D 2003 Published by Elsevier B.V.Keywords: Fusogenic liposome; Hydrophobically modified PEG; Liposome protection; Complement assay; Comb-graft; Protein shielding
1. Introduction liposomal formulations is often limited by their rapid uptakeLiposomes are spheres made up of lipid bilayers, enclos-
ing aqueous volumes [1]. They act as models for biological
membranes and show great potential as drug delivery
vehicles, especially in cancer and gene therapy [2–10].
Certain fusogenic liposomes, such as those incorporating
N-acyl phosphatidylethanolamines (NAPEs), have the abil-
ity to deliver dextran to erythrocyte ghosts [11] and transfect
ovarian cancer cells with DNA encoding a GFP protein
[12]. Nonetheless, the use of fusogenic liposomes and other0005-2736/$ - see front matter D 2003 Published by Elsevier B.V.
doi:10.1016/j.bbamem.2003.08.007
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Monmouth Junction, NJ 08852, USA.by the mononuclear phagocytic system (MPS) [9,13–18].
The concept of sterically stabilized or long circulating
liposomes was first realized in 1987 when lipids modified
with different polymers and polysaccharides were incorpo-
rated into the bilayer to increase the circulation half-life of
liposomes [3,4,7–10,15,17,19–30]. The most effective
coating was formed by integrating distearoylphosphatidyle-
thanolamine-poly(ethylene glycol) (DSPE-PEG5k) with a 5
kDa molecular weight PEG chain [6,7,10, 17,22,26,29,31].
Addition of 2.5 to 10 mol% DSPE-PEG5k into liposomes
made up of distearoylphosphatidylcholine (DSPC) increases
the circulation half-life of liposomes from 0.47 to 8.4 h [17].
It is postulated that increased circulation is a result of
PEG producing a steric barrier to protein binding. The
structure of DSPE-PEG5k, as described by Woodle and
Lasic [3], has the lipid embedded within the hydrophobic
bilayer and the hydrophilic PEG chain protruding into the
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PEG to extend even at low grafting densities [32] and thus
creates a repulsive, steric barrier. Senior [14] observed a
decrease in the rate of protein adsorption onto liposomes
incorporating DSPE-PEGs. These results were confirmed by
Chonn et al. [33] who showed that greater protein binding,
which occurred on bare liposomes, correlated with shorter
circulation half-lives [33]. Liu et al. [16] also concluded that
recognition and uptake of liposomes was determined by
adsorption of specific proteins associated with opsonization,
namely the complement proteins. Therefore, we developed
an automated in vitro assay to measure liposome comple-
ment depletion.
In vitro binding of complement to liposomes has been
shown to correlate inversely with circulation lifetime [20].
The complement system consists of a collection of serum
proteins that act as a cascade for recognition of foreign agents.
The most important of these proteins is C3, which is present
in the bloodstream at levels similar to some immunoglobulins
(1–2 mg/ml). Two consequences of complement activation
are opsonization and lysis of target cells [16].
In this paper, we present the concept of multiply attached
polymer chains as a mechanism for preparing protected
liposomes. The approach exploits recent interest in cooper-
ative binding [34] where multiple relatively weak binding
interactions can lead to strong overall association. The
concept is demonstrated by a series of new PEG-based
comb copolymers with concatenated PEG chains having
hydrophobic anchoring groups between the linked PEG
chains. These polymers allow the comparison of binding
vis a` vis protection with polymers having exactly the same
ratio of PEG to hydrophobe, but with varied cooperativity
by varying the concatenation or degree of polymerization.
These constructs overcome several limitations with the
previous method of stabilizing liposomes with PEG-lipids:
(1) the PEG-lipids must be incorporated during the liposome
formation process rather than adding them to preformed
liposomes [7,9], and (2) the single lipid anchoring limits the
size and amount of PEG polymer that can be attached [22].
The multiply attached PEGs allow the addition of soluble
polymer to the preformed liposomes, which permits greater
flexibility in processing and tailoring liposome formula-
tions. The second limitation arises because the singly
attached PEG will partition off of the liposome surface if
the PEG is too soluble. Experimentally, loss of protection is
observed for PEG molecular weights above 5 kDa [22].
With multiple attachments, higher molecular weight PEGs
can be attached to the liposome with high binding affinities.
The hydrophobically modified PEG polymers (HMPEGs)
used in this study are comb-graft polymers with strictly
alternating monodisperse PEG blocks (Mw 6, 12 or 35 kDa)
bonded to C18 stearylamide hydrophobes, with 2 to 13
hydrophobe anchors per polymer chain [35,36]. We report
the ability of these polymers to associate with fusogenic
liposomes at equilibrium and the ability of the polymers to
shield liposomes from complement binding. We compareour results to DSPE-PEG5k, which has been studied previ-




polyethylene glycol (DSPE-PEG5k), and 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine-N-dodecanoyl (N-C12-
DOPE) were purchased from Avanti Polar Lipids (Alabaster,
AL, USA). 1,1V-Dioctadecyl-3,3,3V,3V-tetramethylindodicar-
bocyanine perchlorate (DiD) was acquired from Molecular
Probes (Eugene, OR, USA). The 0.2-Am polycarbonate
membrane filters, semi-micro disposable cuvettes, and 96-
well plates were obtained from VWR (Bridgeport, NJ, USA).
The HMPEG polymers were synthesized at Rutgers Univer-
sity (Piscataway, NJ, USA) as described by Heitz et al. [35].
Slide-A-Lyzer cassettes with a 10000 MWCO membrane
were procured from Pierce Biotechnology (Rocksford, IL,
USA). Sheep erythrocytes and hemolysin rabbit anti-sheep
erythrocyte stromata serum were purchased from Biowhit-
taker (Walkersville, MD, USA). Lyophilized rat sera, gelatin
veronal buffer (GVB2 +: 0.15 M CaCl2, 0.5 mM MgCl2,
0.1% gelatin, 1.8 mM sodium barbital, 3.1 mM barbituric
acid, 141 mM NaCl, pH 7.4) and gelatin veronal buffer with
EDTA (GVB-EDTA: in addition to the ingredients in
GVB2 + it contains 10 mM EDTA, pH 7.4) were acquired
from Sigma (St. Louis, MO, USA).
2.2. Preparation of liposomes
N-C12-DOPE:DOPC (7:3, mol:mol) large unilamellar
vesicles (LUVs) were prepared as described by Shangguan
et al. [11] with some modifications. The lipids were mixed
in chloroform, dried under reduced pressure using a Bu¨chi
RE 111 Rotovapor and 461 water bath (Bu¨chi Labortechnik
AG, Flawil, Switzerland), then left under vacuum overnight
to remove any residual solvent. The lipid film was hydrated
with a TES buffer solution (10 mM TES, 150 mM NaCl, 0.1
mM EDTA, pH 7.4). After vortexing, the lipid solution
underwent five cycles of freezing in liquid nitrogen and
thawing in a room temperature water bath. The sample was
then extruded 10 times through a 0.2-Am polycarbonate
membrane filter at 250 psi using a 10-ml Lipex extruder
(Northern Lipids, Inc. Vancouver, BC, Canada). The lip-
osomes were stored at 4 jC under nitrogen.
To aid in separation from unbound HMPEG polymer, the
liposome density was increased by encapsulating a sucrose
solution and a fluorescent marker (DiD) was added for
visibility. Sucrose-encapsulating liposomes (N-C12-DOPE:
DOPC:DiD 7:2.9:0.1 mol:mol:mol) were prepared as de-
scribed above except in a sucrose buffer solution (10 mM
TES, 250 mM sucrose, pH 7.4). After the liposomes were
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against the TES buffer (as described above) using a Slide-A-
Lyzer cassette with a 10000 MWCO. Dialysis occurred at 4
jC overnight. Sucrose-encapsulating liposomes incorporat-
ing DSPE-PEG5k were made using the same method
described. The amount of DSPE-PEG5k (x) added was
subtracted from the moles of DOPC (2.9 x), keeping the
amount of DiD and N-C12-DOPE constant. Thus, the
composition of the liposomes containing DSPE-PEG5k is
written as N-C12-DOPE:DOPC:DSPE-PEG5k:DiD
(7:(2.9 x):x:0.1, mol:mol:mol:mol).
The concentration of liposomes in solution was deter-
mined by the phosphate assay as described by Chen et al.
[37]. Sizes of the liposomes were determined by quasi-
elastic light scattering using a NICOMP 270 submicron
particle sizer (NICOMP Instruments, Goleta, CA). Sucrose
encapsulating and buffer encapsulating liposomes had num-
ber-averaged diameters of 62.1F16.4 and 112.8F 28.5 nm,
respectively.
2.3. Adsorption
Liposomes were equilibrated with polymer at a final
concentration of 1.4 mM lipid in TES buffer. Hydrophobi-
cally modified polymer was added, either solubilized in
TES buffer or as dry mass, to achieve the desired
concentration. For DSPE-PEG5k-containing liposomes,
four liposome compositions were prepared with increasing
amounts of polymer coverage (0.14, 0.28, 0.70, and 2.40
times C*, i.e. full surface coverage as calculated from the
dimensions of the PEG loops [38]). The DSPE-PEG5k-
containing liposomes were diluted as described above. All
samples were vortexed and allowed to equilibrate over-
night at room temperature in an Eppendorf 5436 Thermo-
mixer (Brinkman Instruments, Westbury, NY, USA). After
a 24-h equilibration, an initial fraction of 200 Al was
removed. The remaining fraction was then centrifuged at
21000 g in the Eppendorf 5417r Centrifuge (Brinkmann
Instruments, Westbury, NY, USA) at 4 jC. The superna-
tant was removed. Phosphate and PEG assays were
performed on the supernatant and initial fractions to detectTable 1
HMPEG correlation values for quantification of PEG (mg/l) as a function of the
Polymer 0 AM lipid 10 AM lipid
d[OD]/d[Cp] R
2 d[OD]/d[Cp]
HMPEG6k-DP3 0.038 0.987 0.041
HMPEG6k-DP13 0.022 0.971 0.023
HMPEG12k-DP2.5 0.054 0.996 0.053
HMPEG12k-DP5 0.046 0.973 0.050
HMPEG35k-DP2.5 0.049 0.976 0.048
DSPE-PEG5k 0.046 0.931 –
The square of the Pearson product moment correlation coefficient, R2, interprets th
as follows, where a value of one indicates that the estimated value is equal to th
R2 ¼ nðRXY Þ  ðRX ÞðRY Þﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
½nRX 2  ðRX Þ2½nRY 2  ðRY Þ2
q :the amount of PEG per lipid in each sample. The
association constant, K, was calculated by determining







The amount of PEG was quantified by an assay described
by Baleux [39], wherein 25 Al of an iodine-potassium iodide
solution (0.04 M I2, 0.12 M KI) was added to 1 ml of a
diluted sample. Samples were diluted to an optimal adsorp-
tion range (0.1 <AU< 1.0). The diluted sample and color
reagent were mixed in a disposable semi-micro cuvette with
a 1.0-cm path-length. After 5 min, the optical density (OD)
of the solution was determined at ambient temperature by a
UV-2101PC adsorption spectrophotometer (Shimadzu Sci-
entific Instruments, Princeton, NJ, USA) in the visible
region, k = 500 nm. Because the lipid in the assay could
affect the OD, multiple calibration curves were required.
Table 1 describes the correlation between the HMPEG
concentration and OD for 0, 10, 30, and 50 AM lipid.
Calibration curves were completed for DSPE-PEG5k with
varying lipid concentrations; however, there was negligible
dependence in lipid concentration. The slope given is an
average of all of the calibration data taken at different lipid
concentrations. The variation in the assay with different
polymer architectures is due to the differences in hindrance
to helix formation, which is the origin of the colored
complex.
2.5. In vitro complement depletion assay
The complement assay is an in vitro assay that measures
the depletion of complement protein from serum by the
ability of the treated serum to achieve complement-mediated
lysis of activated sheep red blood cells (RBCs). The
complement assay was performed as described by Ahl et
al. [20]. Activation of the sheep erythrocytes was performedoptical density at increasing concentrations of lipid in AM




0.980 0.043 0.980 0.046 0.973
0.980 0.022 0.998 0.023 0.989
0.982 0.056 0.982 0.057 0.988
0.982 0.048 0.997 0.053 0.992
0.978 0.052 0.979 0.053 0.992
– – – – –
e proportion of the variation in Y attributable to the variation in X. It is given
e actual value [53]:
CH50B  CH50BL
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centrifuging at 8000 g for 4 min, and removing the
supernatant. The RBCs were resuspended at 108 cells/ml,
determined by hemacytometry. Next, the RBCs were incu-
bated at 37 jC for 30 min with hemolysin rabbit anti-sheep
erythrocyte stromata serum at 1:500 (v/v). The activated
RBCs were washed three times and resuspended at 108
cells/ml. Activated RBCs were stored at 4 jC and were used
within 1 week.
Each individual complement assay consisted of the
following six samples that were prepared in 200-
Al volumes: TES buffer (the negative control, without
liposomes), 8 mM unmodified liposomes in TES buffer
(the positive control), and four test samples containing
8 mM liposomes in TES buffer with increasing amounts
of polymer. The samples were equilibrated overnight at 4
jC in the thermomixer. Each sample was then incubated
with 100-Al reconstituted rat sera, diluted 1:1 (v/v) with
GVB2 +, at 37 jC for 30 min with gentle shaking.
Addition of 300 Al of GVB2 + was followed by vortexing
and centrifugation at 8000 g for 4 min. We employed a
BiomekR 2000 Laboratory Automation Workstation
(Beckman Coulter, Brea, CA, USA) to perform the
pipetting for the rest of the assay. A 100-Al volume of
supernatant was diluted 1:1 (v/v) followed by eight
successive serial dilutions in GVB2 +. Next, 100 Al of
activated sheep RBCs was added to each dilution and
allowed to incubate for 30 min at 37 jC with gentle
shaking. Hemolysis was quenched by addition of 300 Al of
GVB2 +-EDTA. RBCs that were not lysed were sedi-
mented by centrifuging the samples at 8000 g for 4
min. A 200-Al aliquot from the supernatant of each
sample was transferred to a 96-well plate. Hemolysis
was determined by measuring the optical density of 200
Al of each sample well at 415 nm using a 3550-UV
spectrophotometer plate reader (Bio-Rad Laboratories,
Hercules, CA, USA). Buffer encapsulating N-C12-DOPE:
DOPC:DiD (7:2.9:0.1, mol:mol:mol) liposomes and su-
crose encapsulating N-C12-DOPE:DOPC:DSPE-PEG5k:
DiD (7:(2.9x):x:0.1, mol:mol:mol:mol) were used in
the complement assays. Sucrose encapsulation enables
pelleting of the liposomes but does not interfere with
the complement assay.
The complement assay results are plotted as the
percent hemolysis versus the log of the inverse of the
serum dilution. The CH50, utilized in related literature
[40–42], is the serum dilution required to achieve 50%
hemolysis and is directly proportional to the amount of
active complement in the serum. The CH50 value for
each hemolysis curve was obtained by a linear fit to a
log–log version of the von Krough equation [43]. The
inhibition of liposome complement binding or surface
‘‘protection’’ mediated by HMPEG or DSPE-PEG5k ad-
dition can be quantitatively described as the percentage of
the maximum expected CH50 shift from the CH50 of the
bare liposome to the CH50 of the buffer, i.e. no liposomesample. This can be calculated using the following
equation, where B is buffer, BL is bare liposomes, and
PL is polymer coated liposomes:
% Protection¼ CH50PL  CH50BL  100 ð2Þ3. Theory and models
3.1. Defining coverage, C*
The HMPEGs consist of PEG backbones with C18H37
hydrophobes that are described by the size of the PEG
spacer (molecular weight of PEG between hydrophobes)
and by the number of loops (or degree of polymerization,
denoted DP) [35,36]. The polymers are designated:
HMPEGUXU-DPUYU, where X is the molecular weight of the
PEG spacers in Daltons and Y is the average number of PEG
spacers.
The conformation of the entire PEG polymer chain
tethered to the lipid membrane is shown schematically in
Fig. 1. Our previous studies have shown [38] that the
chain can be treated as a series of subchains, having one-
half the molecular weight of the PEG unit between hydro-
phobes. These subchains obey random-walk statistics and
occupy an area at the interface given by a sphere of
diameter [44]
nmb ¼ 0:76m1=2b ½A˚; ð3Þ
where mb is the molecular weight of the subchain. The
terminal PEG segments of the chain are treated differently
because they are free and not bound at each end; therefore,
they occupy a size corresponding to a sphere of diameter
twice the molecular weight of the internal subchains (see
Fig. 1). The number of spheres, Nb, is equal to two times
the degree of polymerization minus the two ends
(Nb = 2Dp 2). The number-averaged diameter for spheres







From the mean diameter, we determine the area
occupied at the surface from Nbp(n¯/2)
2. The total area
of one polymer is then the number of subchains times the
average area occupied by a subchain. Thus, HMPEG6k-
DP3 has four subchains, a mean diameter of 50 A˚, and
requires an area of 7900 A˚2 per polymer. The amount of
polymer to cover 1-m2 lipid, C*, is 21 nmol, or 0.88 mg,
of HMPEG6k-DP3. Assuming that each lipid head area is
approximately 70 A˚2 [45] and that one half of the lipid is
on the exterior, there are 4.7 Amol of lipid per square
meter. Alternately, we can base the coverage on the
number of hydrophobes required to cover 1-m2 of lipid
Fig. 1. Diagram of (a) a covalently bound PEG to a lipid and (b) a hydrophobically modified PEG associating with a lipid membrane.
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details.
The idea of coverage is based on the amount of
polymer needed to cover the exterior surface area of
liposomes. From the random walk approximation described
above, which we have verified by neutron scattering for
the HMPEG chains [38], we are able to approximate the
area occupied by the HMPEG polymers and the DSPE-
PEG5k polymer. Because the polymers differ greatly in
molecular weight and number of subchains, we find this
the best means for comparison.
3.2. Partitioning model
A partitioning model can describe the association of a
hydrophobe to a phospholipid bilayer. Consider the
bilayer and aqueous solution as two phases. It is
assumed that there is a partition coefficient which relates
the amount of bound polymer per lipid area, [PL]/[L]Table 2
Description of hydrophobically modified PEG polymers










HMPEG6k-DP3 4 50 42 7.9 0.88 0.89
HMPEG6k-DP13 24 43 112 35.0 0.53 1.21
HMPEG12k-DP2.5 3 75 48 13.3 0.60 0.40
HMPEG12k-DP5 8 65 106 26.5 0.66 0.53
HMPEG35k-DP2.5 3 128 138 38.8 0.59 0.14
DSPE-PEG5k 1 54 5781 2.3 0.42 1.55
To convert C* (mg/m2) to Chm*, determine the moles polymer per
4.7 10 6 mol of lipid then multiply by the number of hydrophobes (DP-1)
and 100 to obtain the mol% hydrophobes per lipid, or Chm*.(in mg/m2), with the concentration of free polymer, [P]






where C is the partition coefficient determined by the
difference in free energy of the polymer between the two
phases and c is the activity coefficient, representing the
deviation from ideality [46]. The plot of [PL]/[L] vs. [P]
yields an association isotherm that is linear at low polymer
concentrations and has a decreasing slope due to non-ideal
interactions (c>1) which depends on the polymer type. A
strict thermodynamic analysis will define c as the ratio of
the polymer activity coefficients in both the aqueous and
bilayer phases, c = cP
L/cP
A. Porcar shows how this partition-
ing model relates to a simple binding model where
[P]+[L]f[PL]. The slope, C/c, is equivalent to the associ-
ation constant divided by the number of available sites, K/N
[46].
3.3. Cooperativity
We define cooperativity as the increased probability of
the polymer to remain adsorbed due to its multiple
attachment sites. It is our hypothesis that increasing the
number of hydrophobic anchors on a PEG polymer
increases the cooperativity of the polymer binding to the
liposome membrane while still maintaining the ability to
add the protective polymer after the formation of the
vesicles. The cooperativity of a set of polymers can be
evaluated by comparing the equilibrium constants, which
assesses the ability of a polymer to leave the liposome
surface. Thus, a polymer’s cooperativity relies on its
architecture. For a single hydrophobic anchor attached to
Fig. 2. Association of hydrophobically modified PEG polymers to sucrose
encapsulating fusogenic liposomes. Graph depicts surface coverage, C,
versus the free polymer in solution, Cp, for HMPEG6k-DP3 (o),
HMPEG6k-DP13 (5), HMPEG12k-DP2.5 (w), HMPEG12k-DP5 (),
HMPEG35k-DP2.5 (+), and DSPE-PEG5k (D). Each sample contained 1.4
mM liposomes and 0.1 to 0.6 mg/ml polymer in 1-ml TES buffer. Sucrose
encapsulating liposomes incorporating 0.19, 0.37, 1.11, and 3.70 mol%
DSPE-PEG5k were equilibrated in TES buffer. Samples were equilibrated
for 24 h. Uncertainty comes from the precision of the Baleux assay (see
Table 1) and the precision of the phosphate assay (R2 = 0.992).
Table 3









Error is given as one standard deviation.
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relationship between the anchored polymer and the free
polymer as follows [47]:
K ¼ ½PL½P½L : ð6Þ
The probability of one anchor desorbing can then be
written in terms of the equilibrium constant such that
Pdesorption;1 ¼ 1
K þ 1 : ð7Þ
If K is large, meaning a high affinity for the polymer being
bound, then Pdesorption,1 goes to zero. On the other hand, if K
is small, corresponding to a low affinity of adsorption, the
Pdesorption,1 goes to 1. Assuming that there are no correla-
tions between the anchors, the probability of a multi-loop
polymer leaving the surface is the probability of all of the
anchors being desorbed simultaneously, which for a chain of
x anchors gives:
Pdesorption ¼ ðPdesorption;1Þx: ð8Þ
Therefore, for the multi-looped PEGs in this study, with 2 to
13 anchors, the effect of cooperative interactions should be
pronounced.4. Results and discussion
4.1. Association of HMPEGs with fusogenic liposomes
Polymer binding involves the interplay between hydro-
philicity (molecular weight of PEG) and hydrophobicity
(number of anchors) that controls the HMPEG polymers’
association to liposomes. Fig. 2 and Table 3 are the
binding isotherms and association constants for the
HMPEG polymers and DSPE-PEG5k on N-acyl lipo-
somes. We have chosen to observe adsorption of
HMPEGs to bare liposomes and desorption of DSPE-
PEG5k from liposomes incorporating DSPE-PEG5k.
Attempts were made at producing liposomes containing
HMPEGs similar to the method of liposomes containing
DSPE-PEG5k, i.e. incorporation of the polymer into the
dry lipid before hydration; however, the mixture became
a gel. HMPEGs were added to liposomes at the appro-
priate concentrations and allowed to equilibrate overnight
with gentle shaking. For DSPE-PEG5k liposomes, four
different lipid compositions were prepared into liposomes.
These liposomes were diluted and equilibrated overnight
with gentle shaking. The uncertainty comes from the
precision of the Baleux assay (see Table 1) and the
precision of the phosphate assay (R2 = 0.992).
The polymer with the greatest association to the lipid
membrane is HMPEG6k-DP13 with an association con-
stant of K = 78.1F12.2 (mg/m2)/(mg/ml). In comparison,
HMPEG6k-DP3, which has the same molecular weight
spacer and same ratio of PEG loop hydrophobic anchors,
has an association constant that is 1/13th as strong.
Increasing the cooperativity by f 4-fold increases the
binding 13-fold. A qualitatively similar response is ob-
served for HMPEGs with a 12-kDa spacer, HMPEG12k-
DP2.5 and HMPEG12k-DP5.
At constant number of loops, increasing the molecular
weight of the PEG spacer reveals the effect of the polymer’s
hydrophilicity. We expect that increasing the PEG molecular
weight will reduce the affinity for binding. This is observed
when we compare HMPEGs with 6k and 12k spacers, with
approximately three loops. However, the HMPEG35k-
DP2.5 polymer has an association strength between
HMPEG6k-DP3 and HMPEG12k-DP2.5. This suggests that
Fig. 4. Complement assay for N-C12-DOPE:DOPC 7:3 (mol:mol)
liposomes modified with HMPEG6k-DP13. Graph depicts buffer (.),
liposomes corresponding to 0.34 m2 lipid area (n), liposomes with 0.03 mg
polymer (w), 0.09 mg polymer (), 0.30 mg polymer (5), or 0.90 mg
polymer (D). C* is 0.53 mg/m2.
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and 35k where polymers are not able to pack efficiently,
resulting in a minimum in K.
The adsorption isotherms in Fig. 2 show multi-layer
coverage at high polymer concentrations. Full surface cov-
erage for HMPEG6k-DP13 is calculated to be C* = 0.53 mg/
m2 and we find experimentally a surface coverage C of 0.85
mg/m2 in equilibrium with Cp = 0.02 mg/ml. Sunamoto et al.
[30] studied the adsorption of hydrophobically modified
polysaccharides to liposomes and observed binding levels
greater than theoretical coverage and adsorption increasing
with the number of hydrophobic anchors [30].
An important observation is that DSPE-PEG5k parti-
tions off of the surface of N-acyl liposomes in TES
buffer. After overnight equilibration in TES buffer, 21%
of the added DSPE-PEG5k is in the supernatant. PEG
covalently bound by one lipid has the lowest association
constant {K = 0.41F 0.08(mg/m2)/(mg/ml)} of all the
polymers tested.
4.2. In vitro complement depletion assay
The complement assay measures how well the HMPEGs
and DSPE-PEG5k inhibit in vitro complement binding and
thus ‘‘protect’’ the liposomes from complement opsoniza-Fig. 3. Complement assay for N-C12-DOPE:DOPC 7:3 (mol:mol)
liposomes modified with HMPEG6k-DP3. Graph depicts buffer (.),
liposomes corresponding to 0.34 m2 lipid area (n), liposomes with 0.05 mg
polymer (w), 0.15 mg polymer (), 0.50 mg polymer (5), or 1.50 mg
polymer (D). C* is 0.88 mg/m2. Addition of 0.15 mg HMPEG6k-DP3
shifts the curve to the right instead of towards the left. This is a result of
being portrayed on a logarithmic scale, where the error at this dilution is
large relative to the difference in hemolysis. To obtain the surface coverage
(mg/m2), divide the amount of polymer added by the lipid area, i.e. 1.50 mg
HMPEG6k-DP3/0.34 m2 lipid is 5 mg/m2. The precision of each
measurement is evaluated based on one standard deviation from the mean
for the buffer and liposome controls, 3.1% and 9.1%, respectively.tion. The complement assay results are presented as the
percent hemolysis versus the log of the inverse of the serum
dilution, i.e. Log(1/SD). The typical complement assay
hemolysis curve such as Fig. 3 shows a sigmoidal curveFig. 5. Complement assay for N-C12-DOPE:DOPC 7:3 (mol:mol)
liposomes modified with DSPE-PEG5k. Graph depicts buffer (.),
liposomes corresponding to 0.34 m2 lipid area (n), liposomes with 0.02
mg polymer (w), 0.04 mg polymer (), 0.10 mg polymer (5), or 0.34 mg
polymer (D). C* is 0.42 mg/m2.
Fig. 6. Complement assay with 12-h incubation with rat sera for N-C12-
DOPE:DOPC 7:3 (mol:mol) liposomes modified with DSPE-PEG5k.
Graph depicts buffer (.), liposomes corresponding to 0.34 m2 lipid area
(n), liposomes with 0.02 mg polymer ( w ), 0.04 mg polymer (), 0.10 mg
polymer (5), or 0.34 mg polymer (D). C* is 0.59 mg/m2. The weak
protection shown in (Fig. 5) for a 30-min incubation is eliminated at the
12-h incubation, which shows that DSPE-PEG5k does not protect against
complement binding over long periods of time.
Fig. 7. Complement assay with 12-h incubation with rat sera for N-C12-
DOPE:DOPC 7:3 (mol:mol) liposomes modified with HMPEG6k-DP3.
Graph depicts buffer (.), liposomes corresponding to 0.34 m2 lipid area
(n), liposomes with 0.05 mg polymer ( w ), 0.15 mg polymer (), 0.50 mg
polymer (5), or 1.50 mg polymer (D). C* is 0.88 mg/m2. The results are
qualitatively similar to the results with a 30-min incubation (Fig. 3), which
show that the polymer layer protects against complement binding over the
time interval of 30 min to 12 h.
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hemolysis as the SD decreases and the Log(1/SD) increases.
The CH50 value is the SD at 50% hemolysis and is directly
proportional to the amount of available complement follow-
ing the initial serum incubation. Shifts in the CH50 value
indicate changes in level of complement protection for
different liposome formulations. Unmodified N-C12-
DOPE/DOPE (7:3, mol/mol) liposomes with no PEG pro-
tection and high complement binding levels have low CH50
values typically under 100. We will arbitrarily define the
CH50 values for unmodified liposomes as 0% protection. In
contrast, 100% protection, which we define as the CH50
value of the buffer control, is typically in the 500 to 1000
range. The HMPEG and DSPE-PEG5k liposome formula-
tions we tested in each experiment typically had CH50
values between these two extremes. The precision of each
measurement can be evaluated based on 1 standard devia-
tion from the mean for the buffer and liposome controls:
3.1% and 8.9%, respectively. Additional complement assays
(with 30-min incubation) of HMPEG6k-DP3, HMPEG6k-
DP13, HMPEG12k-DP2.5, and DSPE-PEG5k showed ex-
cellent agreement with the data presented.
The results are presented in the following order: (1)
demonstration of how number and molecular weight of
the PEG spacers produce cooperativity (Figs. 3 and 4);
(2) comparison of DSPE-PEG5k (Fig. 5) versus the
multiply attached chains (Figs. 3 and 4); and (3) evalu-
ation of the time dependence of the DSPE-PEG5k (Fig.6) dissociation in contrast to the stability of the HMPEG
protection (Fig. 7).
4.2.1. Number and molecular weight of the PEG spacers
In Fig. 3, HMPEG6k-DP3 shows 98% protection
when the polymer concentration exceeds full coverage:
C*. For the higher molecular weight spacers, HMPEG12k
series, a degree of polymerization of five (DP5) shows
95% protection at 1.8 times the calculated polymer
coverage (data not shown); however, it requires five
times the calculated polymer coverage for HMPEG12k-
DP2.5 to exhibit 98% shielding from complement binding
(data not shown). The higher molecular weight PEG
group requires more cooperative binding sites to affect
protection. The lower molecular weight PEG (6k) with
lower cooperativity (DP= 3) shows results that are com-
parable to the 12k PEG with the higher DP= 5. There is
a tradeoff between higher molecular weight PEG that
tends to pull the polymer off of the surface and greater
cooperativity that keeps the polymer adsorbed. However,
greater cooperativity alone is not sufficient to protect
against complement binding. Namely, the highly cooper-
ative HMPEG6k-DP13 is unable to shield against com-
plement binding even with the addition of polymer five
times C*, as depicted in Fig. 4.
Based on our previous studies on these highly cooperative
polymers [35,36], where we saw aggregation of these poly-
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ativity leads to inter-chain and polymer self-assembly as
depicted schematically in Fig. 8. The interactions are so
strong that rearrangement of the polymer onto the liposome
surface to form an impenetrable layer is frustrated. Although
the mass of polymer associated with the liposome is high, the
structure of the layer is not optimal and allows diffusion to the
liposome surface. After 24 h, the HMPEG6k-DP13 coated
liposomes display aggregation as a result of bridging. How-
ever, aggregation did not occur in HMPEG12k-DP2.5 and
HMPEG35k-DP2.5 after 1 week. This is a kinetic effect,
however, and may be controlled using excipients. Further
investigation of polymer bridging is needed. The
HMPEG35k-DP2.5 (data not shown) shows less than 50%
protection at five times C*, which is consistent with the high
solubility of the PEG chain and low degree of cooperativity.
This leads to the conclusion that strength of binding alone
does not dictate complement shielding. The structure of the
adsorbed polymer layer also plays a key role in protection.
4.2.2. DSPE-PEG5k versus multiply attached HMPEG
polymers
Fig. 5 illustrates that at 2.4 C* DSPE-PEG5k shows
only 15% protection—compared to 95% at 1.8 C* for
HMPEG12k-DP5. Our previous studies have shown that
the 12k PEG loop with attachment sites at each end be-
haves approximately like two terminally grafted 6k chains
[38]. Therefore, the difference in performance between the
DSPE-PEG5k and the HMPEG12k-DP5 is not due to the
molecular weight of the PEG, but rather due to the co-
operativity of the attachment. The DSPE-PEG5k can be
thought of as the monomer (DP= 1) in the sequence of
HMPEG12k-DP(n).Fig. 8. Schematic of polymer blobs associating with a surface (a) at low
levels of cooperativity, where the polymer can distribute over the surface,
and (b) high levels of cooperativity, which immobilizes the polymer on the
surface and also results in inter- and intra-polymer associations that affect
polymer coverage.It has been shown that incorporating DSPE-PEG5k into
liposomes extends the in vivo circulation time [17,26]. From
the calculation of PEG coil dimensions, 1.55 mol% of
DSPE-PEG5k is needed for complete coverage of a lipo-
some. Blume and Cevc [17] have shown that addition of 2.5
mol% DSPE-PEG5k to a liposome formulation shows
similar protection to 10 mol%. Incorporation of 1.55
mol% corresponds to having 0.42 mg of DSPE-PEG5k
per square meter. The data we present at the highest
DSPE-PEG5k coverage 1.0 mg/m2 is approximately equal
to 3.7 mol%. Therefore, while we have not yet conducted
the in vivo tests, these preliminary results form the basis of
two hypotheses about in vivo experiments: First, HMPEGs
with the appropriate architecture should provide even great-
er protection than DSPE-PEG5k. Second, in vivo tests
would provide a substantiation of the ability of the in vitro
complement binding assay to predict PEG-liposome protec-
tion in vivo. The complement assay has been validated in
vivo for liposomes with different lipid compositions and
modifications [20], but not for PEG-protected liposomes.
4.2.3. Time-dependent dissociation of the DSPE-PEG5k
and stability of HMPEG binding
To broaden our observations to longer circulation
times, we modified the complement assay to extend the
incubation with rat serum from 30 min to 12 h. As
shown in Fig. 6, after an incubation of 12 h, the DSPE-
PEG5k shows no protection from complement binding.
There are two possible explanations. The first is that the
DSPE-PEG5k layer is dynamic enough that even though
the PEG chains are overlapped (C*>1), fluctuations can
expose regions of the liposome surface to which proteins
adsorb. The second explanation, which we feel is more
likely, is that the weaker equilibrium constant of the
DSPE-PEG5k allows dissociation of the polymer from
the liposome surface in the presence of serum. Electro-
static repulsion may aid in the desorption of DSPE-
PEG5k from the negatively charged liposome because it
is itself negatively charged. The HMPEG adsorbed layers
have slow dynamics as we have shown from Spin Echo
Neutron Scattering [38] and therefore we would expect
them to be less prone to protein penetration by the first
mechanism. The multiple attachment of the HMPEGs
slows the dynamics of detachment in the same way that
they increase the energetics of attachment. In the litera-
ture, there does not appear to have been a thorough study
of the dynamics of partitioning of the PEG from the
liposome surface during in vivo tests. Experiments of this
sort would certainly aid in the understanding and appli-
cation of long circulating liposomes.
In contrast to the DSPE-PEG5k, the HMPEG6k-DP3
shows the same high level of protection after 30 min of
incubation (Fig. 3) or 12 h (Fig. 7). The stability of the
HMPEG polymer to resist either displacement from the
liposome surface or penetration by complement protein is
quite remarkable when compared to the DSPE-PEG5k.
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We have demonstrated protection from complement bind-
ing by adsorption of multi-looped, HMPEG polymers to
fusogenic liposomes. A series of polymer samples has been
prepared with monodisperse PEG chains in a strictly alter-
nating copolymer with stearylamide hydrophobes. The poly-
mers are designated: HMPEGUXU-DPUYU, where X is the
molecular weight of the PEG spacers in Daltons and Y is
the average number of polymer chains in the polymer.
Cooperativity is defined by the reduced probability that the
polymers will desorb from the liposome surface. Multiple
attachment sites result in a stronger binding association of the
polymer to liposomes, which increases with number of
anchors. Increasing the molecular weight of PEG between
hydrophobes affects cooperativity by controlling the efficien-
cy of packing. Some polymers, such as HMPEG6k-DP3 and
HMPEG35k-DP2.5, exceed the amount of polymer required
to occupy a specific area, producing multiple layers.
HMPEGs provide excellent protection against comple-
ment binding as measured by the hemolysis assay.
However, binding strength alone does not correlate with
protection. The most resiliently bound HMPEG,
HMPEG6k-DP13, displayed very low levels of protection.
This indicates that the structure of the adsorbed PEG layer
must play a key role in protection. The highly cooperative
HMPEG6k-DP13 may have strong inter- and intra-polymer
associations that prevents the chains from being able to
redistribute uniformly over the liposome surface [48]. The
theories of Rubinstein and Semenov [49] on association of
comb-graft polymers indicate strong inter-molecular inter-
actions leading to phase separation for this class of
polymers. Further experiments using surface plasmon
techniques could address the question of the importance
of intra versus inter-chain associations on PEG adsorption
and complement protection.
The standard technique to prepare long circulating lip-
osomes has been to incorporate DSPE-PEG5k lipids into the
liposome formulation during the initial liposome formation
process. An advantage of the HMPEG polymers is that they
can be added to the liposome formulation after the liposomes
have been formed. This uncouples liposome formulation and
preparation from the protection process. Although HMPEG
polymers have single acyl chain units (as opposed to two tails
of the lipid in DSPE-PEG5k), it is the cooperativity of the
acyl chain’s binding that results in larger equilibrium con-
stants for the HMPEGs. The individual hydrophobes of the
HMPEG can re-equilibrate in solution and distribute on the
liposome surface. However, if cooperativity is too great the
polymer can become immobile as predicted by Rubinstein
and Semenov [49]. With HMPEGs, liposomes with high
polymer coverage and large PEG protective layers can be
produced than is possible with PEG lipids.
The protection from complement binding provided by
HMPEG6k-DP3 is constant over 12 h. In contrast, the
protection by DSPE-PEG5k decreases from a moderatelevel after the normal 30-min assay period to no protection
after 12 h of incubation. The temporal instability of the
DSPE-PEG5k may arise from partitioning of the lipid off of
the liposome surface or fluctuations in surface coverage that
expose bare regions on the liposome surface. In either case,
the HMPEG has neither of these defects.
This study suggests the following rules for the structures
of HMPEG polymers for liposome protection. Equivalent
protection was observed with HMPEG chains with lower
degrees of polymerization and lower molecular weight PEG
(6k) and HMPEG with larger degrees of polymerization and
larger PEG (12k). This indicates a tradeoff is possible
between solubility of the PEG and cooperativity of anchor-
ing. Polymers with too high a level of cooperativity (DP13)
did not perform well, and polymers with too high molecular
weight PEG (35 K) did not function well either.
Currently, there is uncertainty as to the role PEG plays on
the surface of liposomes to produce decreased liposomal
clearance. Although it is assumed that PEG forms a steric
barrier that reduces protein binding [29,50,51], Xu and
Marchant [52] and Price et al. [29] found similar total
protein adsorption profiles on bare liposomes and liposomes
incorporating DSPE-PEG5k. Price et al. [29] speculate that
the steric barrier may affect the interaction between lip-
osomes and macrophages. Our experiments address com-
plement binding; they do not address steric stabilization
between macrophages and liposomes. This would indicate a
direction of future research should be in vivo studies. It may
result that the 12k PEG provides a thicker steric barrier than
the 6k PEG and provides longer circulation times.Acknowledgements
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